Clinical Trials Directory

Trials / Completed

CompletedNCT01492764

Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)

Status
Completed
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
21 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study will test the hypothesis that many human heart rhythm disorders are caused by small localized sources, where brief ablation may successfully eliminate the heart rhythm disorder.

Detailed description

The investigators will enroll patients with documented rapid heart rates from the bottom chambers of the heart (ventricular tachyarrhythmias). During electrophysiological study, the investigators will map the localized sources of these heart rhythm disorders. 1. The 'active' group will prospectively receive brief ablation at localized sources (Focal Impulse and Rotor Modulation, FIRM). 2. The control group will be a historical cohort who have received traditional ablation for this disorder. All patients will be followed for up to 1 year to ensure that they have no recurrent arrhythmias.

Conditions

Timeline

Start date
2011-06-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2011-12-15
Last updated
2019-11-18

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01492764. Inclusion in this directory is not an endorsement.

Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR) (NCT01492764) · Clinical Trials Directory